(VIANEWS) – The NASDAQ ended the session with Horizon Therapeutics (HZNP) rising 4.64% to $94.79 on Friday while NASDAQ rose 3.33% to $12,131.13.


Today’s last reported volume for Horizon Therapeutics is 1742790, 5.81% below its average volume of 1850470.

Horizon Therapeutics’s last close was $90.59, 24.85% under its 52-week high of $120.54.

Horizon Therapeutics’s Sales

Horizon Therapeutics’s sales growth is 12.6% for the ongoing quarter and 4.9% for the next. The company’s growth estimates for the present quarter and the next is a negative 16% and a negative 11.4%, respectively.

Horizon Therapeutics’s Revenue

Year-on-year quarterly revenue growth grew by 36.1%, now sitting on 3.23B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Horizon Therapeutics’s stock is considered to be oversold (<=20).

Horizon Therapeutics’s Stock Yearly Top and Bottom Value

Horizon Therapeutics’s stock is valued at $94.79 at 22:44 EST, way below its 52-week high of $120.54 and way higher than its 52-week low of $82.51.

Horizon Therapeutics’s Moving Average

Horizon Therapeutics’s value is under its 50-day moving average of $102.83 and below its 200-day moving average of $103.84.

More news about Horizon Therapeutics (HZNP).


Please enter your comment!
Please enter your name here